title: Physiological doses of cannabinoids do not adversely affect MCL viability.
authors.forename: Sarah J
authors.initials: SJ
authors.lastname: Richardson
authors.forename: Mathieu
authors.initials: M
authors.lastname: Widmer
authors.forename: John
authors.initials: J
authors.lastname: Zajicek
authors.forename: Simon A
authors.initials: SA
authors.lastname: Rule
mesh_terms: D048588:Benzoxazines / Q000494:pharmacology; D002186:Cannabinoids / Q000494:pharmacology*; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects; D013759:Dronabinol / Q000494:pharmacology; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy* / Q000473:pathology; D009025:Morpholines / Q000494:pharmacology; D009281:Naphthalenes / Q000494:pharmacology